Health News | University of Illinois

NewsBureauillinois
University of Illinois at Urbana-Champaign logo

Health News

Health News

  • 5/19/2015Diana Yates, Life Sciences Editor writer Diana Yates, Life Sciences Editor by Diana Yates, Life Sciences Editor published by Diana Yates, Life Sciences Editor
    A study of older adults at risk of late-onset Alzheimer’s disease found that those who consumed more omega-3 fatty acids did better than their peers on tests of cognitive flexibility – the ability to efficiently switch between tasks – and had a bigger anterior cingulate cortex, a brain region known to contribute to cognitive flexibility.
  • 5/4/2015Sharita Forrest, Education Editor writer Sharita Forrest, Education Editor by Sharita Forrest, Education Editor published by Sharita Forrest, Education Editor
    Infectious disease expert Mosoka P. Fallah, one of five “Ebola fighters” honored as a Person of the Year by Time in 2014, will be among the speakers at an upcoming symposium at the University of Illinois.
  • 4/28/2015Sharita Forrest, News Editor writer Sharita Forrest, News Editor by Sharita Forrest, News Editor published by Sharita Forrest, News Editor
    Scientists have mapped the human genes triggered by the phytonutrients in soy, revealing the complex role the legume plays in both preventing and advancing breast cancer.
  • 4/15/2015Diana Yates, Life Sciences Editor writer Diana Yates, Life Sciences Editor by Diana Yates, Life Sciences Editor published by Diana Yates, Life Sciences Editor
    When scientists exposed pregnant mice to levels of bisphenol A equivalent to those considered safe in humans, three generations of female mouse offspring experienced significant reproductive problems, including declines in fertility, sexual maturity and pregnancy success, the scientists report in the journal Toxicology and Applied Pharmacology.
  • 2/26/2015Diana Yates, Life Sciences Editor writer Diana Yates, Life Sciences Editor by Diana Yates, Life Sciences Editor published by Diana Yates, Life Sciences Editor
    A new drug that prompts cancer cells to self-destruct while sparing healthy cells is now entering phase I clinical trials in humans. The drug, called PAC-1, first showed promise in the treatment of pet dogs with spontaneously occurring cancers, and is still in clinical trials in dogs with osteosarcoma.